Recombinant hepatitis B vaccine market is anticipated to grow at a CAGR of 5.6% during the forecast period. The increasing demand for hepatitis B vaccination and the growing prevalence of hepatitis B is the foremost factors driving the market growth. For instance, in 2019, 30.4 million people (10.5% of all people were estimated to be living with hepatitis B) were aware of their infection, while 6.6 million (22%) of the people diagnosed were on treatment. According to the WHO estimates, the proportion of children under five years of age chronically infected with HBV dropped to just under 1% in 2019. The prevalence of HBV infected population is high, especially in the WHO Western Pacific Region. The prevalence of hepatitis B among the general population in the Western Pacific Region was 5.92% in 2019. It is expected that, with further increasing prevalence, the demand for recombinant hepatitis B vaccines is likely to increase more, which in turn will aid in market growth.
Get Free Sample link @ https://www.omrglobal.com/request-sample/recombinant-hepatitis-b-vaccine-market
Apart from these, the increasing US FDA approval of new drugs can bring lucrative growth opportunities for the market players targeting the recombinant hepatitis B vaccine market. In December 2021, the PreHevbrio vaccine developed by VBI Vaccines got approval from the US FDA for the prevention of infection caused by all known subtypes of hepatitis B virus (HBV) in adults aged 18 years and older. PreHevbrio is the only approved 3-antigen hepatitis B vaccine for adults in the US. Moreover, in December 2018, the USFDA approved VAXELIS and Hepatitis B [Recombinant] Vaccine) for use in children from 6 weeks through 4 years of age. VAXELIS was developed as part of a joint partnership between Merck and Sanofi. VAXELIS is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, and hepatitis B.
A full report of Recombinant Hepatitis B Vaccine Market available @ https://www.omrglobal.com/industry-reports/recombinant-hepatitis-b-vaccine-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Recombinant Hepatitis B Vaccine Market by Type
- 10mcg/ml
- 10mcg/0.5ml
Global Recombinant Hepatitis B Vaccine Market by Application
- Newborn/Children
- Adult
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Bharat Biotech International Ltd.
- CSL Ltd.
- Dynavax Technologies Corp
- Emergent BioSolutions Inc.
- GlaxoSmithKline PLC
- KM Biologics (Meiji Holdings Co., Ltd.)
- LG Chem Ltd.
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Sanofi S.A.
- Serum Institute of India Pvt., Ltd.
- Sinovac Biotech Ltd.
- VBI Vaccines, Inc.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global recombinant hepatitis B vaccine market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/recombinant-hepatitis-b-vaccine-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
